These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35233052)

  • 1. Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor.
    Nashed NT; Aniana A; Ghirlando R; Chiliveri SC; Louis JM
    Commun Biol; 2022 Mar; 5(1):160. PubMed ID: 35233052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmasking the Conformational Stability and Inhibitor Binding to SARS-CoV-2 Main Protease Active Site Mutants and Miniprecursor.
    Kovalevsky A; Coates L; Kneller DW; Ghirlando R; Aniana A; Nashed NT; Louis JM
    J Mol Biol; 2022 Dec; 434(24):167876. PubMed ID: 36334779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of M Protease Inhibitors Encoded by SARS-CoV-2.
    Hung HC; Ke YY; Huang SY; Huang PN; Kung YA; Chang TY; Yen KJ; Peng TT; Chang SE; Huang CT; Tsai YR; Wu SH; Lee SJ; Lin JH; Liu BS; Sung WC; Shih SR; Chen CT; Hsu JT
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32669265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain.
    Nashed NT; Kneller DW; Coates L; Ghirlando R; Aniana A; Kovalevsky A; Louis JM
    Commun Biol; 2022 Sep; 5(1):976. PubMed ID: 36114420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
    Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
    Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition.
    Dey-Rao R; Smith GR; Timilsina U; Falls Z; Samudrala R; Stavrou S; Melendy T
    Antiviral Res; 2021 Nov; 195():105183. PubMed ID: 34626674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular modelling approach for identifying antiviral selenium-containing heterocyclic compounds that inhibit the main protease of SARS-CoV-2: an in silico investigation.
    Rakib A; Nain Z; Sami SA; Mahmud S; Islam A; Ahmed S; Siddiqui ABF; Babu SMOF; Hossain P; Shahriar A; Nainu F; Emran TB; Simal-Gandara J
    Brief Bioinform; 2021 Mar; 22(2):1476-1498. PubMed ID: 33623995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors.
    Silvestrini L; Belhaj N; Comez L; Gerelli Y; Lauria A; Libera V; Mariani P; Marzullo P; Ortore MG; Palumbo Piccionello A; Petrillo C; Savini L; Paciaroni A; Spinozzi F
    Sci Rep; 2021 Apr; 11(1):9283. PubMed ID: 33927258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc
    Panchariya L; Khan WA; Kuila S; Sonkar K; Sahoo S; Ghoshal A; Kumar A; Verma DK; Hasan A; Khan MA; Jain N; Mohapatra AK; Das S; Thakur JK; Maiti S; Nanda RK; Halder R; Sunil S; Arockiasamy A
    Chem Commun (Camb); 2021 Sep; 57(78):10083-10086. PubMed ID: 34514483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extended conformation of SARS-CoV-2 main protease reveals allosteric targets.
    Sun Z; Wang L; Li X; Fan C; Xu J; Shi Z; Qiao H; Lan Z; Zhang X; Li L; Zhou X; Geng Y
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2120913119. PubMed ID: 35324337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirus main protease.
    Cheng SC; Chang GG; Chou CY
    Biophys J; 2010 Apr; 98(7):1327-36. PubMed ID: 20371333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First structure-activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery.
    Amin SA; Banerjee S; Singh S; Qureshi IA; Gayen S; Jha T
    Mol Divers; 2021 Aug; 25(3):1827-1838. PubMed ID: 33400085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors.
    Amin SA; Banerjee S; Ghosh K; Gayen S; Jha T
    Bioorg Med Chem; 2021 Jan; 29():115860. PubMed ID: 33191083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography.
    Kneller DW; Phillips G; Weiss KL; Pant S; Zhang Q; O'Neill HM; Coates L; Kovalevsky A
    J Biol Chem; 2020 Dec; 295(50):17365-17373. PubMed ID: 33060199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug.
    Isgrò C; Sardanelli AM; Palese LL
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33451132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Chou's 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors.
    Pundir H; Joshi T; Joshi T; Sharma P; Mathpal S; Chandra S; Tamta S
    Mol Divers; 2021 Aug; 25(3):1731-1744. PubMed ID: 33079314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Silico Characterization of Masitinib Interaction with SARS-CoV-2 Main Protease.
    Martínez-Ortega U; Figueroa-Figueroa DI; Hernández-Luis F; Aguayo-Ortiz R
    ChemMedChem; 2021 Aug; 16(15):2339-2344. PubMed ID: 34142459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive Molecular Dynamics in Virtual Reality Is an Effective Tool for Flexible Substrate and Inhibitor Docking to the SARS-CoV-2 Main Protease.
    Deeks HM; Walters RK; Barnoud J; Glowacki DR; Mulholland AJ
    J Chem Inf Model; 2020 Dec; 60(12):5803-5814. PubMed ID: 33174415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy.
    Mohammad T; Shamsi A; Anwar S; Umair M; Hussain A; Rehman MT; AlAjmi MF; Islam A; Hassan MI
    Virus Res; 2020 Oct; 288():198102. PubMed ID: 32717346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric Regulation of 3CL Protease of SARS-CoV-2 and SARS-CoV Observed in the Crystal Structure Ensemble.
    Kidera A; Moritsugu K; Ekimoto T; Ikeguchi M
    J Mol Biol; 2021 Dec; 433(24):167324. PubMed ID: 34717972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.